FDA Approves Agent to Shorten Neutropenia Following Chemotherapy

The US Food & Drug Administration is announcing that it has approved tbo-filgrastim for the treatment of the chemotherapy side effect known as neutropenia, (a drop in the body's number of neutrophils, disease-fighting white blood cells). Specifically, tbo-filgrastim is designed to reduce the amount of time cancer chemotherapy patients experience neutropenia.

Neutropenia can be a major problem for cancer patients in treatment as it can make them susceptible to potentially serious infections.

According to the FDA:

"Tbo-filgrastim is intended for use in adults who have cancers other than blood or bone marrow cancers (non-myeloid malignancies) and are taking chemotherapy drugs that cause a substantial decrease in the production of neutrophils in the bone marrow."

Administration of tbo-filgrastim

Tbo-filgrastim works by stimulating the body's bone marrow to boost neutrophil production. It is administered as an injection 24 hours following chemotherapy treatment.

"Supportive care products, such as tbo-filgrastim, reduce or allow for more rapid recovery from side effects of cancer treatments," said Dr. Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research.

Findings from a clinical trial determined that patients receiving tbo-filgrastim recovered from severe neutropenia in 1.1 days, compared with 3.8 days in patients receiving a placebo.

Tbo-filgrastim is a product of Sicor Biotech UAB (part of Teva).

Source: FDA

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...